• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WATCHMAN LAA CLOSURE DEVICE & DELIVERY SYSTEM; SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WATCHMAN LAA CLOSURE DEVICE & DELIVERY SYSTEM; SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL Back to Search Results
Model Number 10371
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Cardiac Perforation (2513); Pericardial Effusion (3271)
Date of Event 03/23/2021
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that a perforation and a pericardial effusion occurred.A left atrial appendage (laa) closure procedure was being performed.A watchman truseal access system (was) was positioned and a 21mm watchman laa closure device & delivery system (wds) were used.The was was positioned in the laa.The was was deep seated, but well buffered by the pigtail, and the sheath remained in the same position upon removal of the pigtail catheter.When the closure device was deployed, it appeared the feet of the device jumped forward as the shoulders were unsheathed.Angiography revealed a perforation/pericardial effusion noted distal to the feet of the device by contrast leaking into the pericardium in the area of the transverse sinus and posterior cavity.Protamine was immediately administered to reverse heparin.The device was released in the laa after all release criteria was noted to be met.A pericardiocentesis was attempted to treat the pericardial effusion, however, a fluid return could not be seen as there was such a minimal effusion.The effusion was monitored with transesophageal echocardiography (tee) for 30 minutes post procedure and never increased in size.The patient was stable the entire procedure and is expected to fully recover.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WATCHMAN LAA CLOSURE DEVICE & DELIVERY SYSTEM
Common Device Name
SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key11665711
Report Number2134265-2021-03854
Device Sequence Number14227549
Product Code NGV
UDI-Device Identifier08714729838227
UDI-Public08714729838227
Combination Product (Y/N)N
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
P130013
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 04/14/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date11/20/2022
Device Model Number10371
Device Catalogue Number10371
Device Lot Number0024805036
Was Device Available for Evaluation? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 03/23/2021
Initial Report FDA Received Date04/14/2021
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age87 YR
-
-